Download medicine data

You can download data related to medicines published on EMA's website in table format. The website automatically updates these data tables overnight.

To stay up-to-date with new and updated information on this website, see:

• What's new

All relevant information and documents on medicines authorised at a European Union (EU) level are available on medicine pages. This includes:

• Full scientific assessment reports
• Public-friendly overviews in question-and-answer format
• Package leaflets

These pages also contain information on medicines for which the European Commission has refused a marketing authorisation, or has suspended or withdrawn the marketing authorisation after approval.

More up-to-date information on veterinary medicinal products is available on the Veterinary Medicines Information website.

For more information, see:

• Medicines for human use under evaluation

During the post-authorisation stage of a medicine life-cycle, marketing authorisation holders can submit an application to change the terms of marketing authorisation. This is known as a variation.

At any stage of the assessment process, applicants can withdraw the application to EMA.

Information on approved post-authorisation procedures is available on medicine pages.

For more information, see:

• Variations including extensions of marketing authorisations

For more information, see:

• Referral procedures: human medicines
• Referral procedures: veterinary medicines

For more information, see:

• Paediatric medicines: Overview
• Paediatric investigation plans

For more information, see:

• Orphan designation: Overview

Marketing authorisation holders periodically submit PSURs following a medicine's authorisation. EMA and national competent authorities carry out a single joint assessment of all medicines containing the same active substance or combination of active substances to determine if there is a need to update marketing authorisations.

For more information, see:

• Periodic safety update reports (PSURs)

For more information, see:

• Direct healthcare professional communications (DHPCs)
• Direct animal healthcare professional communications (DaHPCs)

For each shortage, additional information about the situation in a specific country may be available from the national competent authority.

For more information, see:

• Medicine shortages and availability issues
• Availability of medicines before and during crises

For more information, see:

• Herbal medicinal products

For more information, see:

• Medicines for use outside the European Union